Despite Reg Challenges, China Market Access Gradually Improving
This article was originally published in PharmAsia News
Executive Summary
China's regulatory environment remains a struggle for device firms seeking to gain marketing or manufacturing footholds in the country, but meaningful government efforts to improve the business climate are making a dent, suggest device executives who are focused on the region
You may also be interested in...
Global View: Talking Harmonization And China With Jeffrey Gren
The just-retired Commerce official Jeffrey Gren discusses the impact of globalization on the medical device industry, and the issues the sector is facing in China.
Global View: Talking Harmonization And China With Jeffrey Gren
The just-retired Commerce official Jeffrey Gren discusses the impact of globalization on the medical device industry, and the issues the sector is facing in China, in an interview with “The Gray Sheet.” Gren retired from the U.S. Department of Commerce in January after decades of focusing on device and drug trade issues.
Boston Sci In China: Investment Chases Big Growth
While Boston Scientific’s core cardiology business units continue to face steep growth challenges in the U.S, China’s massive population remains essentially an untapped market.